Nutex Health, Inc. (NUTX) Insider Trading Activity

NASDAQ$205.5+25.92 (14.43%)
Market Cap
$1.23B
Sector
Healthcare
Industry
Medical—Care Facilities
Rank in Sector
265 of 849
Rank in Industry
14 of 39

NUTX Insider Trading Activity

NUTX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$148,237
5
83
Sells
$43,493
1
17

Related Transactions

Bates Jon ChristianChief Financial Officer
1
$102,532
0
$0
$102,532
Hosseinion WarrenPresident
1
$23,706
0
$0
$23,706
Jaumot Frank Edirector
1
$14,033
0
$0
$14,033
Montgomery Pamela W.Chief Legal Officer-Healthcare
1
$7,021
0
$0
$7,021
Spears Kelvindirector
1
$945
0
$0
$945
Saunders Scott Jdirector
0
$0
1
$43,493
$-43,493

About Nutex Health, Inc.

Nutex Health, Inc. functions as a technology-powered enterprise delivering healthcare services, structured into two key segments: its Hospital division and its Population Health Management division. The Hospital division is tasked with developing and overseeing various healthcare models, encompassing micro-hospitals, specialized medical centers, and hospital outpatient facilities. This segment currently owns and operates 21 locations spanning eight different states. Meanwhile, the Population Health Management division establishes and manages …

Insider Activity of Nutex Health, Inc.

Over the last 12 months, insiders at Nutex Health, Inc. have bought $148,237 and sold $43,493 worth of Nutex Health, Inc. stock.

On average, over the past 5 years, insiders at Nutex Health, Inc. have bought $356,979 and sold $850,213 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Bates Jon Christian (Chief Financial Officer) — $102,532. Hosseinion Warren (President) — $23,706. Jaumot Frank E (director) — $14,033.

The last purchase of 150 shares for transaction amount of $14,033 was made by Jaumot Frank E (director) on 2026‑03‑20.

List of Insider Buy and Sell Transactions, Nutex Health, Inc.

2026-09-18SaleSaunders Scott Jdirector
203
0.003%
$214.25
$43,493
-1.23%
2026-03-20PurchaseJaumot Frank Edirector
150
0.0026%
$93.56
$14,033
+81.45%
2026-03-19PurchaseHosseinion WarrenPresident
252
0.0042%
$94.07
$23,706
+68.64%
2026-03-17PurchaseSpears Kelvindirector
10
0.0002%
$94.46
$945
+67.57%
2026-03-13PurchaseMontgomery Pamela W.Chief Legal Officer-Healthcare
79
0.0013%
$88.87
$7,021
+77.07%
2025-11-25PurchaseBates Jon ChristianChief Financial Officer
750
0.0126%
$136.71
$102,532
+28.81%
2025-04-08PurchaseBates Jon ChristianChief Financial Officer
1,000
0.0196%
$81.81
$81,810
+34.97%
2024-09-06PurchaseDogan MeeshanthiniChief Executive Officer
68,965
0.0256%
$0.29
$20,000
+161.46%
2024-09-06PurchaseDogan TimurChief Technology Officer
68,965
0.0256%
$0.29
$20,000
+161.46%
2024-08-22PurchaseBates Jon ChristianChief Financial Officer
1,350
0.0371%
$21.46
$28,970
+143.68%
2024-08-20PurchaseDeTillio JoshuaChief Operating Officer
575
0.0128%
$17.40
$10,005
+150.70%
2024-08-19PurchaseDeTillio JoshuaChief Operating Officer
1,300
0.0297%
$17.85
$23,205
+191.84%
2024-06-12PurchaseDeTillio JoshuaChief Operating Officer
20,000
0.0138%
$0.54
$10,800
+504.63%
2024-05-30PurchaseVo Thomas T.Chief Executive Officer
2,986
0.0025%
$0.66
$1,971
+374.14%
2024-05-29PurchaseVo Thomas T.Chief Executive Officer
3,768
0.0033%
$0.68
$2,562
+355.72%
2024-05-28PurchaseVo Thomas T.Chief Executive Officer
48,394
0.0434%
$0.70
$33,876
+344.44%
2024-05-13PurchaseVo Thomas T.Chief Executive Officer
17,330
0.0153%
$0.69
$11,958
+306.29%
2023-11-20PurchaseVo Thomas T.Chief Executive Officer
275,200
0.042%
$0.23
$62,195
-48.39%
2023-11-17PurchaseVo Thomas T.Chief Executive Officer
224,800
0.0337%
$0.23
$51,704
-51.08%
2023-11-15PurchaseDeTillio JoshuaChief Operating Officer
140,000
0.0215%
$0.24
$34,174
-53.72%
Total: 51
*Gray background shows transactions not older than one year

Insider Historical Profitability

62.7%
Spears Kelvindirector
32137
0.4693%
$5.77M10
Hosseinion WarrenPresident
7765
0.1134%
$1.39M25
Bates Jon ChristianChief Financial Officer
5638
0.0823%
$1.01M40
+41.74%
Montgomery Pamela W.Chief Legal Officer-Healthcare
2758
0.0403%
$495,281.6420
<0.0001%
Jaumot Frank Edirector
150
0.0022%
$26,937.0010
Vo Thomas T.Chief Executive Officer
18060663
263.7374%
$3.24B140
+56.62%
Dogan MeeshanthiniChief Executive Officer
1655429
24.174%
$297.28M10
+161.46%
Breslin Terence Martin
724496
10.5797%
$130.1M10
Meiri Daviddirector
266627
3.8935%
$47.88M10
Dogan TimurChief Technology Officer
197310
2.8813%
$35.43M10
+161.46%
Waters John Jdirector
196262
2.866%
$35.24M20
<0.0001%
Creem Mitchelldirector
81746
1.1937%
$14.68M20
<0.0001%
Grenas Cheryl Yvonnedirector
10000
0.146%
$1.8M10
<0.0001%
Reed Michael Leedirector
10000
0.146%
$1.8M10
<0.0001%
DeTillio JoshuaChief Operating Officer
4808
0.0702%
$863,420.6440
+198.36%
*Gray background shows insiders who have made transactions during last year

NUTX Institutional Investors: Active Positions

Increased Positions64+61.54%413,297+17.08%
Decreased Positions44-42.31%203,306-8.4%
New Positions29New100,911New
Sold Out Positions9Sold Out41,224Sold Out
Total Postitions124+19.23%3M+8.68%

NUTX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Topline Capital Management, Llc$82,478.007.95%556,567+247,436+80.04%2025-09-30
Pertento Partners Llp$40,074.003.86%270,421+270,421New2025-09-30
Blackrock, Inc.$38,882.003.75%262,378+14,431+5.82%2025-09-30
Vanguard Group Inc$31,854.003.07%214,954+24,275+12.73%2025-09-30
Morgan Stanley$17,902.001.73%120,801+89,493+285.85%2025-09-30
American Century Companies Inc$17,061.001.65%115,131+11,068+10.64%2025-09-30
Millennium Management Llc$13,840.001.33%93,396+61,308+191.06%2025-09-30
Geode Capital Management, Llc$12,022.001.16%81,124+2,265+2.87%2025-09-30
State Street Corp$11,520.001.11%77,740+14,919+23.75%2025-09-30
Ubs Group Ag$10,194.000.98%68,791+23,316+51.27%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.